Literature DB >> 33340564

Gold nanoparticle-mediated bubbles in cancer nanotechnology.

Ali Shakeri-Zadeh1, Hajar Zareyi2, Roghayeh Sheervalilou3, Sophie Laurent4, Habib Ghaznavi5, Hadi Samadian6.   

Abstract

Microbubbles (MBs) have been extensively investigated in the field of biomedicine for the past few decades. Ultrasound and laser are the most frequently used sources of energy to produce MBs. Traditional acoustic methods induce MBs with poor localized areas of action. A high energy level is required to generate MBs through the focused continuous laser, which can be harmful to healthy tissues. As an alternative, plasmonic light-responsive nanoparticles, such as gold nanoparticles (AuNPs), are preferably used with continuous laser to decrease the energy threshold and reduce the bubbles area of action. It is also well-known that the utilization of the pulsed lasers instead of the continuous lasers decreases the needed AuNPs doses as well as laser power threshold. When well-confined bubbles are generated in biological environments, they play their own unique mechanical and optical roles. The collapse of a bubble can mechanically affect its surrounding area. Such a capability can be used for cargo delivery to cancer cells and cell surgery, destruction, and transfection. Moreover, the excellent ability of light scattering makes the bubbles suitable for cancer imaging. This review firstly provides an overview of the fundamental aspects of AuNPs-mediated bubbles and then their emerging applications in the field of cancer nanotechnology will be reviewed. Although the pre-clinical studies on the AuNP-mediated bubbles have shown promising data, it seems that this technique would not be applicable to every kind of cancer. The clinical application of this technique may basically be limited to the good accessible lesions like the superficial, intracavity and intraluminal tumors. The other essential challenges against the clinical translation of AuNP-mediated bubbles are also discussed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bubble; Cancer; Gold nanoparticles; Nanotechnology; Theranostics

Year:  2020        PMID: 33340564     DOI: 10.1016/j.jconrel.2020.12.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  Effects of folate-conjugated Fe2O3@Au core-shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies.

Authors:  Habib Ghaznavi; Mohammad Reza Hajinezhad; Milad Shirvaliloo; Sheida Shahraki; Kourosh Shahraki; Ramin Saravani; Sakine Shirvalilou; Omolbanin Shahraki; Ziba Nazarlou; Roghayeh Sheervalilou; Saman Sargazi
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

2.  Hyaluronic Acid Hydrogels Hybridized With Au-Triptolide Nanoparticles for Intraarticular Targeted Multi-Therapy of Rheumatoid Arthritis.

Authors:  Chenxi Li; Rui Liu; Yurong Song; Youwen Chen; Dongjie Zhu; Liuchunyang Yu; Qingcai Huang; Zhengjia Zhang; Zeyu Xue; Zhenglai Hua; Cheng Lu; Aiping Lu; Yuanyan Liu
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

3.  A 2D nanotheranostic platform based on graphene oxide and phase-change materials for bimodal CT/MR imaging, NIR-activated drug release, and synergistic thermo-chemotherapy.

Authors:  Mehri Mirrahimi; Zahra Alamzadeh; Jaber Beik; Abolfazl Sarikhani; Mahdie Mousavi; Rasoul Irajirad; Tahereh Khani; Elnaz S Davani; Ali Farashahi; Tahereh Shakerian Ardakani; Jeff W M Bulte; Habib Ghaznavi; Ali Shakeri-Zadeh
Journal:  Nanotheranostics       Date:  2022-05-24

Review 4.  Engineering Gold Nanostructures for Cancer Treatment: Spherical Nanoparticles, Nanorods, and Atomically Precise Nanoclusters.

Authors:  Wei He; Guanyu Ma; Quanli Shen; Zhenghua Tang
Journal:  Nanomaterials (Basel)       Date:  2022-05-19       Impact factor: 5.719

5.  Folic Acid and Chitosan-Functionalized Gold Nanorods and Triangular Silver Nanoplates for the Delivery of Anticancer Agents.

Authors:  You Jeong Lee; Yeon-Jeong Kim; Youmie Park
Journal:  Int J Nanomedicine       Date:  2022-04-29

Review 6.  Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic.

Authors:  Roghayeh Sheervalilou; Milad Shirvaliloo; Saman Sargazi; Sakine Shirvalilou; Omolbanin Shahraki; Younes Pilehvar-Soltanahmadi; Alireza Sarhadi; Ziba Nazarlou; Habib Ghaznavi; Samideh Khoei
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-12       Impact factor: 4.813

Review 7.  Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy.

Authors:  Xiaoling Ding; Xinchen Sun; Huihui Cai; Lei Wu; Ying Liu; Yu Zhao; Dingjingyu Zhou; Guiping Yu; Xiaorong Zhou
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

Review 8.  Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication.

Authors:  Milad Rasouli; Nadia Fallah; Sander Bekeschus
Journal:  Oxid Med Cell Longev       Date:  2021-10-27       Impact factor: 6.543

Review 9.  Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy.

Authors:  Iqra Fatima; Abbas Rahdar; Saman Sargazi; Mahmood Barani; Mohadeseh Hassanisaadi; Vijay Kumar Thakur
Journal:  J Funct Biomater       Date:  2021-12-16

Review 10.  Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management.

Authors:  Rabia Arshad; Iqra Fatima; Saman Sargazi; Abbas Rahdar; Milad Karamzadeh-Jahromi; Sadanand Pandey; Ana M Díez-Pascual; Muhammad Bilal
Journal:  Nanomaterials (Basel)       Date:  2021-12-08       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.